Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Nanotechnol., 11 July 2025

Sec. Biomedical Nanotechnology

Volume 7 - 2025 | https://doi.org/10.3389/fnano.2025.1655276

Correction: Advancement in nanobubble technology: enhancing drug and nutraceutical delivery with focus on bioavailability, targeted therapy, safety, and sustainability

This article is a correction to:

  1. Advancement in Nanobubble Technology: Enhancing Drug and Nutraceutical Delivery with Focus on Bioavailability, Targeted Therapy, Safety, and Sustainability

    1. Read original article
Frontiers Production Office Frontiers Production Office*
  • Frontiers Media SA, Lausanne, Switzerland

A Correction on
Advancement in nanobubble technology: enhancing drug and nutraceutical delivery with focus on bioavailability, targeted therapy, safety, and sustainability

by Awlqadr FH, Noreen S, Altemimi AB, Mohammed OA, Qadir SA, Ahmed DH, Alkanan ZT, Tsakali E, Van Impe JFM, Kozak D, Abd El-Maksoud AA, Ashraf MA and Abedelmaksoud TG (2025). Front. Nanotechnol. 7:1548593. doi: 10.3389/fnano.2025.1548593

The affiliation of the author Zina T. Alkanan was erroneously given as 2 Department of Pharmaceutical Technology, Institute of Pharmacy, University of Innsbruck, Innsbruck, Austria. The correct affiliation is 4 Food Science Department, College of Agriculture, University of Basrah, Basrah, Iraq.

The original version of this article has been updated.

Keywords: nanobubbles (NBs), drug delivery, nutraceutical delivery, neurodegenerative disease, sustainability

Citation: Frontiers Production Office (2025) Correction: Advancement in nanobubble technology: enhancing drug and nutraceutical delivery with focus on bioavailability, targeted therapy, safety, and sustainability. Front. Nanotechnol. 7:1655276. doi: 10.3389/fnano.2025.1655276

Received: 27 June 2025; Accepted: 27 June 2025;
Published: 11 July 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Production Office, cHJvZHVjdGlvbi5vZmZpY2VAZnJvbnRpZXJzaW4ub3Jn

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.